PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Teriparatide
Presentation Product Chemical substance Chapter Items dispensed
Forsteo 20micrograms/80microlitres dose inj 2.4ml pf pens
0606010U0BBABAC
Forsteo Teriparatide Endocrine System 49
Teriparatide 20microg/80microL dose inj 2.4ml pf dispos dev
0606010U0AAACAC
Teriparatide Teriparatide Endocrine System 11
Teriparatide 20micrograms/80microlitres dose inj 2.4ml cart
0606010U0AAAEAE
Teriparatide Teriparatide Endocrine System 6
Movymia 20microg/80microlitres dose inj 2.4ml cart with pen
0606010U0BDAAAD
Movymia Teriparatide Endocrine System 2
Movymia 20micrograms/80microlitres dose inj 2.4ml cartridge
0606010U0BDABAE
Movymia Teriparatide Endocrine System 1
Terrosa 20microg/80microlitres dose inj 2.4ml cart with pen
0606010U0BEABAD
Terrosa Teriparatide Endocrine System 1
Forsteo 20micrograms/80microlitres inj 3ml pf dispos dev
0606010U0BBAAAA
Forsteo Teriparatide Endocrine System No data available
Lusama 20micrograms/80microlitres dose inj 2.4ml pf pens
0606010U0BGAAAC
Lusama Teriparatide Endocrine System No data available
Sondelbay 20micrograms/80microlitres dose inj 2.4ml pf pens
0606010U0BFAAAC
Sondelbay Teriparatide Endocrine System No data available
Teriparatide 20microg/80microL dose inj 2.4ml cart with dev
0606010U0AAADAD
Teriparatide Teriparatide Endocrine System No data available
Teriparatide 750micrograms/3ml inj pf dispos dev
0606010U0AAAAAA
Teriparatide Teriparatide Endocrine System No data available
Terrosa 20micrograms/80microlitres dose inj 2.4ml cartridge
0606010U0BEAAAE
Terrosa Teriparatide Endocrine System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.